The court continued the freeze on restrictions imposed by Louisiana on the drug, mifepristone. The post Supreme Court Allows Temporary Access to Abortion Drug By Mail appeared first on The American Conservative .
The Supreme Court ruled Thursday to continue its temporary stay on Louisiana’s restrictions on mifepristone, a popular abortion drug. This freeze was requested by the plaintiff Danco Laboratories, LLC, the manufacturers of the drug, until the court delivers a concrete ruling. Mifepristone is one of two widely used abortion drugs which Louisiana last fall mandated be dispensed in person. According to Axios , telehealth prescriptions and deliveries make up more than 60 percent of abortions in the U.S. healthcare system. Offering his dissent , Associate Justice Clarence Thomas rejected the argument for a continued freeze. “Applicants are not entitled to a stay of an adverse court order based on lost profits from their criminal…Open
A divided Supreme Court on Thursday indefinitely extended a freeze on strict new restrictions for dispensing the widely used abortion pill mifepristone while an underlying legal fight over the drug plays out. Why it matters: The widely expected order provides legal certainty for pharmacies, telehealth companies and clinicians caught up in the latest battle over accessing the pill. - Justices Samuel Alito and Clarence Thomas dissented. - Teleprescribing and mailing of abortion drugs now account for more than 60% of all abortions in the health system. Driving the news: Alito had issued two earlier stays freezing a ruling by the 5th U.S. Circuit Court of Appeals that would have required patients to see a provider in person before getting…
The Supreme Court extended a freeze Monday on new restrictions for dispensing the widely used abortion pill mifepristone , allowing the continued mail-order prescribing of the drug. Why it matters: The extension, which runs through 5 p.m. Thursday, provides a reprieve for pharmacies, telehealth companies and clinicians caught up in the latest legal tussle over accessing the pill. Driving the news: Justice Samuel Alito extended a stay he granted a week ago in response to requests from drugmakers Danco Laboratories and GenBioPro to restore access to mifepristone via teleprescribing and the mails. - Anti-abortion advocates have been calling for a rollback of a Biden administration policy that expanded access to mifepristone and removed a…
The Supreme Court temporarily restored mail-order prescribing of the widely used abortion drug mifepristone Monday, pausing an appeals court decision that dramatically limited access to the pills. Why it matters: The stay of at least one week issued by Justice Samuel Alito doesn't settle an underlying legal challenge to rules for dispensing the drug that could make abortion access a top-tier issue heading into the midterms. - But it's likely to reduce confusion among pharmacies, telehealth firms and providers over what's allowed, even in states where abortion is legal. Driving the news: The stay was in response to requests from drugmakers Danco Laboratories and GenBioPro to restore access to mifepristone via teleprescribing and the…
State of the Union: The court ruled that allowing the pills to be mailed undermines the state’s abortion law. The post FDA Blocks Mail Distribution of Abortion Pills appeared first on The American Conservative .
A federal appeals court on Friday blocked the mailing of mifepristone prescriptions, sharply curtailing access to one of the most common methods of abortion in the United States. The unanimous ruling by a three-judge panel of the Fifth U.S. Circuit Court of Appeals requires the abortion pill to be dispensed only in person at clinics, overruling Food and Drug Administration regulations that allowed it to be distributed by mail. Judge Kyle Duncan wrote that mailing the drug into Louisiana undermines the state’s abortion ban. Danco Laboratories, the manufacturer of mifepristone, has appealed to the U.S. Supreme Court to overturn the decision. The Supreme Court unanimously ruled against an attempt by pro-life groups to restrict access…Open